Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine?
1
Health Services Center for Students and Staff, Dokkyo Medical University, 880 Kitakobayashi, Mibu 321-0293, Tochigi, Japan
2
Department of Psychiatry, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu 321-0293, Tochigi, Japan
3
Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu 321-0293, Tochigi, Japan
*
Author to whom correspondence should be addressed.
Vaccines 2021, 9(11), 1295; https://doi.org/10.3390/vaccines9111295
Submission received: 8 October 2021
/
Revised: 26 October 2021
/
Accepted: 5 November 2021
/
Published: 8 November 2021
Abstract
:Medical students may come in contact with individuals infected with COVID-19 in their clinical rotations. A high level of acceptance of vaccination is needed for them to protect their health and the health of patients from this disease. The objectives of this study were to (1) obtain information on medical students’ attitudes toward COVID-19 vaccination, (2) assess factors associated with students’ attitudes, and (3) identify predictors of their willingness to receive a third dose of the COVID-19 vaccine. Using a cross-sectional design, we conducted a questionnaire survey of medical students in July 2021. For this survey, we employed a 15-item questionnaire specifically developed to assess the students’ attitudes toward COVID-19 vaccination. Of the 742 distributed questionnaires, 496 (294 males and 202 females) were completed. Among all the participants, 89.1% (442/496) received the second dose of the vaccine, and 90.7% (450/496) indicated that they would hypothetically receive the COVID-19 vaccine in the future. Furthermore, 84.5% (419/496) of all the participants were willing to receive a third dose of the vaccine. Regarding willingness to receive a third dose of the COVID-19 vaccine, multiple logistic regression models showed that students’ grade and their responses to Q1 (positive attitude toward vaccination), Q9 (belief in the protection offered by COVID-19 vaccination), Q10 (concern about the excessively rapid development of COVID-19 vaccines), Q12 (need for aspects of pre-pandemic life), and Q14 (concern about the sustainability of immunity) had significant associations with this outcome. Confidence in vaccines, relaxation of mobility restrictions, and concern about the sustainability of immunity motivate willingness to receive a third dose of the COVID-19 vaccine in medical students.
1. Introduction
Since coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described based on a cluster of cases in China, there have been more than 236 million confirmed cases of COVID-19, including 4.8 million deaths, and the disease has caused an ongoing global pandemic [1]. Preventive measures such as social distancing, quarantining, and wearing masks, have become an essential part of daily life, and this pandemic has affected a wide range of people’s lives, including mental, physical, and social aspects [2,3,4,5]. To eliminate this pandemic, widespread vaccination against COVID-19 has been regarded as a promising measure.
In Japan, COVID-19 vaccination was launched on 17 February 2021 for healthcare workers; the first vaccine approved in Japan, Comirnaty (produced by Pfizer/BioNTech), was based on the use of nucleoside-modified RNA (modRNA), which encodes the spike protein found on the surface of SARS-CoV-2 [6,7]. Medical students in Japan are not involved in clinical practice against COVID-19. However, in clinical rotations, students may come in contact individuals infected with this disease, such as healthcare workers [8]. A high level of acceptance of vaccination is needed for medical students to protect their health and the health of patients from COVID-19 [9,10]. Vaccination is successful only when there are high rates of acceptance and coverage. Healthcare workers are considered an important source of information on vaccination for the general population [11,12], and medical students with a positive attitude toward vaccines might encourage widespread vaccination [9].
Recently, the need for a third dose of the COVID-19 vaccine has been discussed due to the threat of the B.1.617.2 (delta) variant and the need for the protection of immunocompromised individuals [13]. A three-dose regimen could reduce the risk of COVID-19 infection and reverse the waning of neutralizing antibodies after two doses of the vaccine [14,15,16]. However, the best timing of a third dose or boosting with heterologous vaccines is controversial [13,17,18]. Furthermore, there are still many countries facing very large waves of the disease with large unvaccinated populations. In addition, rich countries’ three-dose booster regimens could impede global vaccination [19]. At present, the administration of a third COVID-19 vaccine dose is still controversial.
The objectives of this investigation were to (1) obtain information on medical students’ attitudes toward COVID-19 vaccination, (2) assess factors associated with students’ attitudes, and (3) identify predictors of their willingness to receive a third dose of the COVID-19 vaccine. To the best of our knowledge, this article presents the first study on the willingness to receive a third dose of the COVID-19 vaccine.
2. Methods
2.1. Participants and Measures
Based on the Health Services Center for Students and Staff (HSCSS) database, more than 80% (648/742) of medical students at Dokkyo Medical University completed a two-dose regimen of the Comirnaty vaccine between April and May in 2021. To assess the attitudes of medical students toward COVID-19 vaccination, the HSCSS conducted a questionnaire survey for medical students at the university in July 2021. For this survey, a brief 15-item questionnaire based on the relevant literature was developed. The surveys were distributed to all medical students at Dokkyo Medical University School of Medicine. Of the 742 distributed questionnaires, 496 (294 males and 202 females) were completed. The response rates among students from Grade 1 to Grade 6, were 73.8% (93/126), 73.2% (90/123), 68.6% (83/121), 69.5% (89/128), 61.2% (63/103), and 55.3% (78/141), respectively. The detailed questions are summarized in Table 1. Students rated the item regarding their attitudes toward COVID-19 vaccination on a 4-point scale (1 = strongly agree, 2 = agree, 3 = disagree, 4 = strongly disagree). Those answering 1 or 2 were grouped as answering “agree”, while those who answered 3 or 4 were considered as answering “disagree”. Sociodemographic data (age, grade, and sex) and history of allergic reaction, anaphylaxis, asthma, atopic dermatitis, and COVID-19 vaccination were obtained from the HSCSS database. Furthermore, we classified students by status of COVID-19 vaccination and willingness to receive the vaccine (Q15) (Figure 1). Students who were unvaccinated or dropped out after the first dose of the COVID-19 vaccine and were willing to receive the vaccine in the future were classified as Group A. On the other hand, those who completed the second dose of the COVID-19 vaccine and were not willing to receive the vaccine in the future were classified as Group B. In addition, those who completed the second dose of the COVID-19 vaccine and were willing to receive the vaccine as the third dose in the future were classified as Group C.
2.2. Ethics
This protocol received approval from the Ethics Committee of Dokkyo Medical University School of Medicine (Approval number: 2021–016), and it conformed to the provisions of the Declaration of Helsinki. The requirement for written informed consent was waived by the Ethics Committee since the study involved record review only. However, information on the study was disclosed on our web page, and students were free to opt out.
2.3. Statistical Analysis
Descriptive analyses of the demographic and clinical characteristics were performed. To compare the main variables between groups, unpaired Student’s t-tests were performed to analyze the continuous variables, and chi-square tests were performed to analyze the categorical variables. The data are presented as the means ± SDs or percentages. Multivariate logistic regression analysis with a forward selection method was performed to assess the effects of the students’ attitudes (Q1–Q14 for students) and covariates (age, grade, sex, and history of allergic reaction, anaphylaxis, asthma, and atopic dermatitis) on the completion of COVID-19 vaccination with a two-dose regimen. In another analysis, we employed multivariate logistic regression analysis with a forward selection method to assess the effects of the students’ attitudes and the same covariates on the willingness to receive the COVID-19 vaccine in the future (Q15).
Furthermore, we also conducted multivariate logistic regression analysis with a forward selection method to assess the effects of students’ attitudes and the same covariates on the changing willingness to receive the COVID-19 vaccine in the future (Groups A and B). Regarding those who were willing to receive a third dose of the COVID-19 vaccine (Group C), multivariate logistic regression analysis with a forward selection method was employed as the dependent variable and students’ attitudes and the same covariates were employed as independent variables. A value of p < 0.05 was considered significant. The data were analyzed using SPSS software for Windows (Version 27).
3. Results
Among all the participants, 90.7% (450/496) indicated that they would hypothetically receive the COVID-19 vaccine in the future (Q15) (Table 1). The mean age and grade of all participants were 21.1 ± 2.5 years and 3.4 ± 1.7, respectively. In the analysis of the influence of students’ characteristics (Table 2) on their willingness to receive the COVID-19 vaccine in the future (Q15), no differences in any other characteristics were observed.
To assess the influence of attitudes (Q1–Q14) toward COVID-19 vaccination as independent variables of students’ completion of COVID-19 vaccination with a two-dose regimen, we performed a multivariate logistic regression analysis with a forward selection method. Higher grade and students’ responses to Q1 (positive attitude toward vaccination), Q4 (effect of parents’ opinions), Q10 (concern about the excessively rapid development of COVID-19 vaccines), and Q12 (need for aspects of pre-pandemic life) showed significant associations. In an analysis of students’ willingness to receive the COVID-19 vaccine in the future as a dependent variable, patients’ responses to Q1, Q9 (belief in the protection offered by COVID-19 vaccination), Q10, Q12, and Q14 (concern about the sustainability of immunity) were significantly associated with willingness (Table 3).
Table 4 shows the factors associated with the changed willingness to receive the COVID-19 vaccine. Regarding Group A, responses to Q10 and Q14 showed a significant association. In addition, students’ grade and responses to Q2 (fear of needles/shots), Q4, and Q12 were significantly associated in Group B.
Regarding willingness to receive a third dose of the COVID-19 vaccine, multiple logistic regression models showed that students’ grade and responses to Q1, Q9, Q10, Q12, and Q14 had significant associations with this outcome (Table 5).
4. Discussion
This study was conducted to investigate the attitudes of medical students toward COVID-19 vaccination. In our survey, almost all the respondents (98.4%; 488/496) stated that they approved of vaccinations in principle (Q1), and most of them (92.8%; 460/496) considered COVID-19 vaccination to be necessary for them to travel or go out to eat and drink as in pre-pandemic life (Q12). Among the respondents, 89.1% (442/496) had received the second dose of the vaccine, and 90.7% (450/496) indicated that they would hypothetically receive the COVID-19 vaccine in the future. Furthermore, 84.5% (419/496) of all the participants were willing to receive a third dose of the vaccine. Although the majority of the students (75.6%; 375/496) stated that the vaccines provide a high degree of protection against COVID-19 (Q9), 67.3% (334/496) were concerned about the sustainability of immunity by the vaccine (Q14). In addition, a nonnegligible number of the students (46.0%; 228/496) stated that the vaccine was developed too rapidly (Q10).
Vaccine hesitancy, which is defined as a delay in acceptance or refusal of vaccinations even though vaccination services are made available, poses a barrier to achieving widespread vaccination against COVID-19. A previous international meta-analysis of the proportion of vaccine hesitancy among the general population suggested that 20% of the participants intended to refuse COVID-19 vaccination [20]. Regarding medical students, the rate of vaccine hesitancy reported in previous studies has varied considerably due to the different definitions of the concept or timing of investigation in each study [9,10,21,22,23]. The availability of vaccination, or the percentage of vaccinated students might be associated with vaccination hesitancy. Several studies have shown that medical students express higher intentions to be vaccinated than the general population [24], nonmedical students [25,26], nursing students [27], and dental students [28]. A recent study conducted in Japan showed that 14 to 16% of the younger (15-39 years old) subgroup expressed COVID-19 vaccine hesitancy in terms of their hypothetical intention to be vaccinated and that vaccination intention was associated with several factors, including younger age, female sex, and living alone [29]. In our results, 10.9% (54/496) of the students did not complete the second dose of the vaccine. Although hypothetical intention is not a real-life decision, the rate of vaccine hesitancy in the general population seems to be higher than that in medical students who were not vaccinated twice.
Fear of vaccination side effects has been reported to be associated with COVID-19 vaccine hesitancy in medical students as well as the general population [9,26,29,30]. In our analysis, concern about the side effects of COVID-19 vaccination (Q8) was not associated with students’ attitudes toward or completion of vaccination. A possible explanation is that the majority of our participants received the second dose of the vaccine, and their experience might have decreased their concern about the side effects of COVID-19 vaccination. However, concern about the rapid development of COVID-19 vaccines (Q10) still had a significant impact on students’ decision making regarding COVID-19 vaccinations.
Few studies have focused on the effect of parents’ opinions on medical students’ decision making regarding COVID-19 vaccinations. We found significant associations between the effect of parents’ opinion (Q4) and COVID-19 vaccine hesitancy in medical students. Although recommendation from family or friends was indicated as a reason for both receiving and not receiving vaccines [29], it is difficult to explain the association between the effect of parents’ opinion and COVID-19 vaccine hesitancy in medical students. The association found in Q4 might be related to a cultural issue.
Fear of needles has been associated with COVID-19 vaccine hesitancy [23,31] in nonmedical student populations, and our results concerning Q2 might support previous findings. However, our findings also indicated that even students with a fear of needles received a second dose of the COVID-19 vaccine. In our results, students in higher grades had lower vaccine hesitancy. The amount of medical education and need for protection against COVID-19 in clinical rotations might motivate their willingness [32].
Most of our participants considered COVID-19 vaccination to be necessary to resume aspects of pre-pandemic life (Q12). Mobility restrictions were enforced by the government to abate the spread of COVID-19, resulting in motivation to resume going-out activities after the end of the pandemic [33]. However, even for vaccinated individuals, basic preventive measures such as wearing masks are needed to prevent COVID-19 vaccine breakthrough infections for a while [13].
Several limitations of this study should be acknowledged. First, our study is limited by the fact that students were asked about behavioral intention to receive COVID-19 vaccination in the future. The responses of participants may not reflect implementation intention when faced with the decision of actual vaccination. Second, the questionnaires were not standardized, which could lead to problems in interpreting the results. Furthermore, we employed a Likert scale, which leaves room for a subjective overevaluation of the self-perceived degree of comprehension and knowledge. Third, several potential confounding factors, such as depressive symptoms and psychological distress, which may contribute to willingness to receive the COVID-19 vaccine, were not assessed in this study. Fourth, the study population consisted of students from one medical university; therefore, it may not reflect the characteristics of all Japanese medical students.
5. Conclusions
Most of the medical students completed the second dose of the COVID-19 vaccine and were willing to receive a third dose. Confidence in vaccines, relaxation of mobility restrictions, and concern about the sustainability of immunity motivated willingness to receive the third dose of the COVID-19 vaccine in medical students. Our findings provide key information related to medical student vaccination in Japan and education about COVID-19 vaccination.
Author Contributions
Conceptualization, N.S.; methodology, N.S. and N.Y.-F.; validation, K.S.; formal analysis, N.S.; writing—original draft preparation, N.S.; writing—review and editing, N.Y.-F., A.F. and K.S.; supervision, K.S.; project administration, N.S. All authors have read and agreed to the published version of the manuscript.
Funding
The authors received no specific funding for this work.
Institutional Review Board Statement
This protocol received approval from the Ethics Committee of Dokkyo Medical University School of Medicine (Approval number: 2021–016), and it conformed to the provisions of the Declaration of Helsinki.
Informed Consent Statement
The requirement for written informed consent was waived by the Ethics Committee since the study involved record review only. However, information on the study was disclosed on our web page, and students were free to opt out.
Data Availability Statement
The Ethics Committee of Dokkyo Medical University School of Medicine has set restrictions on data sharing because the data contain potentially identifying or sensitive student information. Please contact the institutional review board of the Ethics Committee of Dokkyo Medical University School of Medicine for data requests. Upon request, the ethics committee will decide whether to share the data.
Acknowledgments
The authors would like to thank all of the coworkers (Kaoru Nakabayashi, Yuriko Ami, Kyoko Nemoto, Yumiko Matsumoto, Sanae Abe, Yoko Kuroda, and Shiori Sakata) for their skillful contributions to the data collection and management.
Conflicts of Interest
The authors declare no conflict of interest.
References
- World Health Organization. COVID-19 Dashboard. Available online: https://covid19.who.int/ (accessed on 8 October 2021).
- Azuma, K.; Nojiri, T.; Kawashima, M.; Hanai, A.; Ayaki, M.; Tsubota, K.; TRF-Japan Study Group. Possible favorable lifestyle changes owing to the coronavirus disease 2019 (COVID-19) pandemic among middle-aged Japanese women: An ancillary survey of the TRF-Japan study using the original “Taberhythm” smartphone app. PLoS ONE 2021, 16, e0248935. [Google Scholar] [CrossRef]
- Murayama, H.; Okubo, R.; Tabuchi, T. Increase in Social Isolation during the COVID-19 Pandemic and Its Association with Mental Health: Findings from the JACSIS 2020 Study. Int. J. Environ. Res. Public Health 2021, 18, 8238. [Google Scholar] [CrossRef]
- Nagasu, M.; Muto, K.; Yamamoto, I. Impacts of anxiety and socioeconomic factors on mental health in the early phases of the COVID-19 pandemic in the general population in Japan: A web-based survey. PLoS ONE 2021, 16, e0247705. [Google Scholar] [CrossRef]
- Tezuka, M.; Nagata, T.; Saeki, K.; Tsuboi, Y.; Fukutani, N. Association between Abrupt Change to Teleworking and Physical Symptoms During the Coronavirus Disease 2019 (COVID-19) Emergency Declaration in Japan. J. Occup. Environ. Med. 2021, in press. [Google Scholar] [CrossRef]
- Ministry of Health, Labour and Welfare: Notice on COVID-19 Vaccination. Available online: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00218.html (accessed on 14 September 2021). (In Japanese)
- Polack, F.P.; Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Pérez Marc, G.; Moreira, E.D.; Zerbini, C.; et al. C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. N. Engl. J. Med. 2020, 383, 2603–2615. [Google Scholar] [CrossRef] [PubMed]
- Harries, A.J.; Lee, C.; Jones, L.; Rodriguez, R.M.; Davis, J.A.; Boysen-Osborn, M.; Kashima, K.J.; Krane, N.K.; Rae, G.; Kman, N.; et al. Effects of the COVID-19 pandemic on medical students: A multicenter quantitative study. BMC Med. Educ. 2021, 21, 14. [Google Scholar] [CrossRef]
- Lucia, V.C.; Kelekar, A.; Afonso, N.M. COVID-19 vaccine hesitancy among medical students. J. Public Health 2021, 43, 445–449. [Google Scholar] [CrossRef]
- Saied, S.M.; Saied, E.M.; Kabbash, I.A.; Abdo, S.A.E. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J. Med. Virol. 2021, 93, 4280–4291. [Google Scholar] [CrossRef] [PubMed]
- Herzog, R.; Álvarez-Pasquin, M.J.; Díaz, C.; Del Barrio, J.L.; Estrada, J.M.; Gil, Á. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 2013, 13, 154. [Google Scholar] [CrossRef] [Green Version]
- Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef] [PubMed]
- The Lancet Infectious Diseases. COVID-19 vaccine equity and booster doses. Lancet. Infect. Dis. 2021, 21, 1193. [Google Scholar] [CrossRef]
- Bar-On, Y.M.; Goldberg, Y.; Mandel, M.; Bodenheimer, O.; Freedman, L.; Kalkstein, N.; Mizrahi, B.; Alroy-Preis, S.; Ash, N.; Milo, R.; et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N. Engl. J. Med. 2021, in press. [Google Scholar] [CrossRef]
- Kamar, N.; Abravanel, F.; Marion, O.; Couat, C.; Izopet, J.; Del Bello, A. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N. Engl. J. Med. 2021, 385, 661–662. [Google Scholar] [CrossRef]
- Yue, L.; Xie, T.; Yang, T.; Zhou, J.; Chen, H.; Zhu, H.; Li, H.; Xiang, H.; Wang, J.; Yang, H.; et al. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine. J. Med. Virol. 2021, in press. [Google Scholar] [CrossRef]
- Zhang, J.; He, Q.; An, C.; Mao, Q.; Gao, F.; Bian, L.; Wu, X.; Wang, Q.; Liu, P.; Song, L.; et al. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg. Microbes. Infect. 2021, 10, 1598–1608. [Google Scholar] [CrossRef]
- Krause, P.R.; Fleming, T.R.; Peto, R.; Longini, I.M.; Figueroa, J.P.; Sterne, J.A.C.; Cravioto, A.; Rees, H.; Higgins, J.P.T.; Boutron, I.; et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021, 398, 1377–1380. [Google Scholar] [CrossRef]
- Mahase, E. Covid-19: Third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021, 373, n1659. [Google Scholar] [CrossRef] [PubMed]
- Robinson, E.; Jones, A.; Lesser, I.; Daly, M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine 2021, 39, 2024–2034. [Google Scholar] [CrossRef] [PubMed]
- Bălan, A.; Bejan, I.; Bonciu, S.; Eni, C.E.; Ruță, S. Romanian Medical Students’ Attitude towards and Perceived Knowledge on COVID-19 Vaccination. Vaccines 2021, 9, 854. [Google Scholar] [CrossRef]
- Talarek, E.; Warzecha, J.; Banasiuk, M.; Banaszkiewicz, A. Influenza Vaccination Coverage and Intention to Receive Hypothetical Ebola and COVID-19 Vaccines among Medical Students. Vaccines 2021, 9, 709. [Google Scholar] [CrossRef] [PubMed]
- Kanyike, A.M.; Olum, R.; Kajjimu, J.; Ojilong, D.; Akech, G.M.; Nassozi, D.R.; Agira, D.; Wamala, N.K.; Asiimwe, A.; Matovu, D.; et al. Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda. Trop. Med. Health 2021, 49, 37. [Google Scholar] [CrossRef]
- Petravić, L.; Arh, R.; Gabrovec, T.; Jazbec, L.; Rupčić, N.; Starešinič, N.; Zorman, L.; Pretnar, A.; Srakar, A.; Zwitter, M.; et al. Factors Affecting Attitudes towards COVID-19 Vaccination: An Online Survey in Slovenia. Vaccines 2021, 9, 247. [Google Scholar] [CrossRef]
- Pastorino, R.; Villani, L.; Mariani, M.; Ricciardi, W.; Graffigna, G.; Boccia, S. Impact of COVID-19 Pandemic on Flu and COVID-19 Vaccination Intentions among University Students. Vaccines 2021, 9, 70. [Google Scholar] [CrossRef]
- Szmyd, B.; Bartoszek, A.; Karuga, F.F.; Staniecka, K.; Błaszczyk, M.; Radek, M. Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors. Vaccines 2021, 9, 128. [Google Scholar] [CrossRef] [PubMed]
- Rosental, H.; Shmueli, L. Integrating Health Behavior Theories to Predict COVID-19 Vaccine Acceptance: Differences between Medical Students and Nursing Students. Vaccines 2021, 9, 783. [Google Scholar] [CrossRef] [PubMed]
- Kelekar, A.K.; Lucia, V.C.; Afonso, N.M.; Mascarenhas, A.K. COVID-19 vaccine acceptance and hesitancy among dental and medical students. J. Am. Dent. Assoc. 2021, 152, 596–603. [Google Scholar] [CrossRef]
- Okubo, R.; Yoshioka, T.; Ohfuji, S.; Matsuo, T.; Tabuchi, T. COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan. Vaccines 2021, 9, 662. [Google Scholar] [CrossRef]
- Xu, B.; Gao, X.; Zhang, X.; Hu, Y.; Yang, H.; Zhou, Y.H. Real-World Acceptance of COVID-19 Vaccines among Healthcare Workers in Perinatal Medicine in China. Vaccines 2021, 9, 704. [Google Scholar] [CrossRef] [PubMed]
- Graupensperger, S.; Abdallah, D.A.; Lee, C.M. Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine. Vaccine 2021, 39, 2060–2067. [Google Scholar] [CrossRef]
- Sovicova, M.; Zibolenova, J.; Svihrova, V.; Hudeckova, H. Odds Ratio Estimation of Medical Students’ Attitudes towards COVID-19 Vaccination. Int. J. Environ. Res. Public Health. 2021, 18, 6815. [Google Scholar] [CrossRef]
- Sakai, H.; Shimizu, M.; Yoshimura, T.; Hato, E. Psychological Reactance to Mobility Restrictions Due to the COVID-19 Pandemic: A Japanese Population Study. Front. Psychol. 2021, 12, 655022. [Google Scholar] [CrossRef] [PubMed]
Figure 1.
Status of COVID-19 vaccination and willingness to receive the vaccine. Note. The box shaded with vertical lines represents students (Group A) who were unvaccinated or dropped out after first dose of the COVID-19 vaccine but who were willing to receive the vaccine in future. On the other hand, the box shaded with horizontal lines represents those (Group B) who completed the second dose of the COVID-19 vaccine but were not willing to receive the vaccine in future. Furthermore, the box shaded with a gray background represents those (Group C) who were willing to receive a third dose of the COVID-19 vaccine.
Figure 1.
Status of COVID-19 vaccination and willingness to receive the vaccine. Note. The box shaded with vertical lines represents students (Group A) who were unvaccinated or dropped out after first dose of the COVID-19 vaccine but who were willing to receive the vaccine in future. On the other hand, the box shaded with horizontal lines represents those (Group B) who completed the second dose of the COVID-19 vaccine but were not willing to receive the vaccine in future. Furthermore, the box shaded with a gray background represents those (Group C) who were willing to receive a third dose of the COVID-19 vaccine.
Table 1.
Attitudes of medical students toward COVID-19 vaccination (n = 496).
| Strongly | Srtongly | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Agree | (n) | Agree | (n) | Disagree | (n) | Disagree | (n) | ||
| Q1 | In principle, I approve of vaccinations. | 51.2% | (254) | 47.2% | (234) | 1.2% | (6) | 0.4% | (2) |
| Q2 | I have a fear of needles/shots. | 5.0% | (25) | 24.8% | (123) | 40.3% | (200) | 29.8% | (148) |
| Q3 | If I get COVID-19, I will develop severe symptoms. | 3.0% | (15) | 27.6% | (137) | 61.9% | (307) | 7.5% | (37) |
| Q4 | Parents’ opinion affected my decision of whether to receive the COVID-19 vaccine. | 13.1% | (65) | 32.7% | (162) | 29.8% | (148) | 24.4% | (121) |
| Q5 | Friends’ opinion affected my decision of whether to receive the COVID-19 vaccine. | 6.3% | (31) | 33.3% | (165) | 33.1% | (164) | 27.4% | (136) |
| Q6 | News media affected my decision of whether to receive the COVID-19 vaccine. | 4.0% | (20) | 33.1% | (164) | 35.3% | (175) | 27.6% | (137) |
| Q7 | Being free of charge affected my decision of whether to receive the COVID-19 vaccine. | 25.2% | (125) | 34.1% | (169) | 23.4% | (116) | 17.3% | (86) |
| Q8 | In general, the COVID-19 vaccine has apparent side effects. | 22.8% | (113) | 51.4% | (255) | 22.8% | (113) | 3.0% | (15) |
| Q9 | The vaccines provide a high degree of protection against COVID-19. | 11.9% | (59) | 63.7% | (316) | 22.0% | (109) | 2.4% | (12) |
| Q10 | The COVID-19 vaccine was developed too rapidly. | 10.3% | (51) | 35.7% | (177) | 48.2% | (239) | 5.8% | (29) |
| Q11 | I have received sufficient information about COVID-19 vaccination. | 7.3% | (36) | 49.6% | (246) | 38.9% | (193) | 4.2% | (21) |
| Q12 | COVID-19 vaccination is needed for me to travel or go out to eat and drink as in pre-pandemic life. | 44.0% | (218) | 48.8% | (242) | 6.0% | (30) | 1.2% | (6) |
| Q13 | The COVID-19 pandemic will continue for a long time. | 26.2% | (25) | 62.7% | (25) | 10.1% | (25) | 1.0% | (25) |
| Q14 | I have concerns about the sustainability of immunity by the COVID-19 vaccine. | 9.9% | (49) | 57.5% | (285) | 29.0% | (144) | 3.6% | (18) |
| Q15 | I am willing to get the COVID-19 vaccine in the future. | 40.7% | (202) | 50.0% | (248) | 7.7% | (38) | 1.6% | (8) |
Abbreviations: COVID-19, Coronavirus disease 2019.
Table 2.
Characteristics according to willingness to receive the COVID-19 vaccine in future.
| Students’ Willingness to Receive | ||||||
|---|---|---|---|---|---|---|
| Yes | No | |||||
| Age | 21.1 ± 2.4 | 20.8 ± 2.6 | ||||
| Grade | 3.4 ± 1.7 | 3.0 ± 1.6 | ||||
| Sex (male) | 58.9% | (264/450) | 65.2% | (30/46) | ||
| Past history of allergic reaction due to | ||||||
| food | 11.5% | (50/435) | 6.7% | (3/45) | ||
| medication | 5.1% | (22/435) | 2.2% | (1/45) | ||
| animal | 5.5% | (24/436) | 4.4% | (2/46) | ||
| pollen from plants and trees | 25.1% | (109/437) | 20.0% | (9/47) | ||
| house dust mites | 9.9% | (43/438) | 6.7% | (3/45) | ||
| unknown allergen | 3.9% | (17/435) | 4.4% | (2/46) | ||
| Past history of anaphylaxis | 0.5% | (2/435) | 0.0% | (0/435) | ||
| Past history of asthma | 3.4% | (15/435) | 2.2% | (1/45) | ||
| Past history of atopic dermatitis | 2.8% | (12/435) | 0.0% | (0/435) | ||
Table 3.
Factors associated with completion of COVID-19 vaccination with a two-dose regimen and willingness to receive the COVID-19 vaccine in the future.
Table 3.
Factors associated with completion of COVID-19 vaccination with a two-dose regimen and willingness to receive the COVID-19 vaccine in the future.
| Odds Ratio | 95% | CI | Wald Value | p Value | ||
|---|---|---|---|---|---|---|
| Completion of COVID-19 vaccination with a two-dose regimen | ||||||
| Grade | 1.57 | 1.24 | - | 1.98 | 13.71 | <0.001 |
| Q1 | 28.66 | 2.71 | - | 303.45 | 7.77 | 0.005 |
| Q4 | 0.41 | 0.21 | - | 0.83 | 6.24 | 0.013 |
| Q10 | 0.47 | 0.24 | - | 0.91 | 5.05 | 0.025 |
| Q12 | 10.49 | 4.09 | - | 26.89 | 23.94 | <0.001 |
| Willingness to receive the COVID-19 vaccine in future | ||||||
| Q1 | 8.61 | 1.44 | - | 51.55 | 5.56 | 0.018 |
| Q9 | 2.52 | 1.23 | - | 5.18 | 6.32 | 0.012 |
| Q10 | 0.26 | 0.12 | - | 0.55 | 12.25 | <0.001 |
| Q12 | 5.14 | 2.18 | - | 12.09 | 14.02 | <0.001 |
| Q14 | 2.53 | 1.22 | - | 5.28 | 6.15 | 0.013 |
Multivariate logistic regression analysis using a forward selection method was carried out with completion of COVID-19 vaccination with a two-dose regimen as the dependent variable and age, sex, grade, past history of allergic reaction (due to food, medication, animal, pollen from plants and trees, house dust mite, unknown allergen), anaphylaxis, asthma, atopic dermatitis, and attitudes toward COVID-19 vaccination (Q1–Q14) as independent variables. Multivariate logistic regression analysis using a forward selection method was carried out with willingness to receive COVID-19 vaccination in the future (Q15) as the dependent variable and the same factors as independent variables. Abbreviations: COVID-19, Coronavirus disease 2019; CI, Confidence interval.
Table 4.
Factors associated with changes in willingness to receive the COVID-19 vaccine in the future.
Table 4.
Factors associated with changes in willingness to receive the COVID-19 vaccine in the future.
| Odds Ratio | 95% | CI | Wald Value | p Value | ||
|---|---|---|---|---|---|---|
| Group A students who were unvaccinated or dropped out after the first dose of the COVID-19 vaccine but who are willing to receive the vaccine in the future. | ||||||
| Q10 | 4.50 | 1.69 | - | 11.96 | 9.11 | 0.003 |
| Q14 | 0.31 | 0.13 | - | 0.74 | 6.95 | 0.008 |
| Group B students who received a second dose of the COVID-19 vaccine but are not willing to receive the vaccine in the future. | ||||||
| Grade | 0.58 | 0.43 | - | 0.79 | 11.77 | 0.001 |
| Q2 | 3.23 | 1.44 | - | 7.25 | 8.12 | 0.004 |
| Q4 | 2.95 | 1.23 | - | 7.09 | 5.83 | 0.016 |
| Q12 | 0.26 | 0.08 | - | 0.93 | 4.33 | 0.038 |
Multivariate logistic regression analysis using a forward selection method was carried out with changed willingness to receive COVID-19 vaccination in future (Groups A and B) as the dependent variable and age, sex, grade, past history of allergic reaction (due to food, medication, animal, pollen from plants and trees, house dust mites, unknown allergen), anaphylaxis, asthma, atopic dermatitis, and attitudes toward COVID-19 vaccination (Q1–Q14) as independent variables. Abbreviations: COVID-19, Coronavirus disease 2019; CI, Confidence interval.
Table 5.
Factors associated with willingness to receive a third dose of the COVID-19 vaccine among medical students.
Table 5.
Factors associated with willingness to receive a third dose of the COVID-19 vaccine among medical students.
| Odds Ratio | 95% | CI | Wald Value | p Value | ||
|---|---|---|---|---|---|---|
| Grade | 1.41 | 1.16 | - | 1.70 | 11.93 | 0.001 |
| Q1 | 9.85 | 1.08 | - | 89.83 | 4.11 | 0.043 |
| Q9 | 2.18 | 1.19 | - | 4.01 | 6.29 | 0.012 |
| Q10 | 0.32 | 0.17 | - | 0.57 | 14.61 | <0.001 |
| Q12 | 5.83 | 2.53 | - | 13.43 | 17.18 | <0.001 |
| Q14 | 2.20 | 1.20 | - | 4.02 | 6.53 | 0.011 |
Multivariate logistic regression analysis using a forward selection method was carried out with willingness to receive a third dose of the COVID-19 vaccine in the future (Group C) as the dependent variable and age, sex, grade, past history of allergic reaction (due to food, medication, animal, pollen from plants and trees, house dust mites, unknown allergen), anaphylaxis, asthma, and atopic dermatitis, and attitudes toward COVID-19 vaccination (Q1-Q14) as independent variables. Abbreviations: COVID-19, Coronavirus disease 2019; CI, Confidence interval.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Sugawara, N.; Yasui-Furukori, N.; Fukushima, A.; Shimoda, K. Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine? Vaccines 2021, 9, 1295. https://doi.org/10.3390/vaccines9111295
AMA Style
Sugawara N, Yasui-Furukori N, Fukushima A, Shimoda K. Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine? Vaccines. 2021; 9(11):1295. https://doi.org/10.3390/vaccines9111295
Chicago/Turabian StyleSugawara, Norio, Norio Yasui-Furukori, Atsuhito Fukushima, and Kazutaka Shimoda. 2021. "Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine?" Vaccines 9, no. 11: 1295. https://doi.org/10.3390/vaccines9111295
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
